Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Merck Jockeys for Schering Position | Contract Pharma

What are you searching for?

Sign in
Breaking News

Merck Jockeys for Schering Position

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck KgA has revealed that it has been acquiring shares of Schering AG, pushing its stake in the company near 20%, even as Bayer‘s deadline to acquire Schering closes in.

Merck previously bid to acquire Schering, but was trumped by Bayer’s $21.5 billion offer for that company. As part of that offer, Bayer began acquiring shares in Schering. The company needs 75% of shareholders to vote in favor of the takeover at a June 14 meeting. Bayer currently owns 61.5% of Schering shares, but that number is changing by the hour.

Merck bid 77 euros per share with its March offer, while Bayer proposed 86 euros per share. Schering is currently trading at 86 euros per share

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters